Ypsomed aims to further strengthen its position as the world’s leading independent developer and manufacturer of injection systems for the self-injection of liquid medicines under the umbrella-brand of YDS Ypsomed Delivery Systems.
Ypsomed aims to further strengthen its market position as a major supplier of diabetes equipment and the product- and service program mylife Diabetescare.
Our strategy is based on four pillars:
Innovation & Digital Health
Our investment in research and development is above average.
When developing our new technologies, the focus is on added value for those affected, the customers and society.
Access & Expansion
Our products help improve medical care for people with chronic diseases globally.
We wish to serve the widest possible range of medical indications to make life easier for affected people.
Responsibility & Engagement
We are committed to acting responsibly towards our employees, our partners and society.
We strive for a closed-loop economy and to reduce our carbon footprint.
Platforms & Operational Excellence
Due to our established platform approach and the resulting ease of scaling capacities, we are able to provide our customers with products quickly and reliably.
We operate according to the principles of lean management and continuously optimise our highly automated work processes. This enables us to further expand our cost leadership.
